Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Bristol-Myers Squibb and Allied Minds form new research enterprise

      Americas
      Bristol-Myers Squibb and Allied Minds have formed a new jointly owned enterprise, Allied-Bristol Life Sciences, aimed at advancing discoveries of biopharmaceutical innovations at leading...

      FDA approves Bayer’s Eylea to treat diabetic macular edema

      Americas
      Bayer has announced the US Food and Drug Administration's (FDA) approval of Eylea, an aflibercept solution for injection into the eye for the treatment...

      FDA plans to take steps to enhance the collection and availability of clinical trial data on demographic subgroups.

      Americas
        By: Margaret A. Hamburg, M.D.Margaret A. Hamburg, M.D., is Commissioner of the U.S. Food and Drug Administration   August 20, 2014, Today...

      Boston Strategics begins Phase I trial of anti-cancer agent to treat haematologic malignancies

      Americas
      Boston Strategics (BSC) has started a Phase I clinical trial of Fujifilm's anti-cancer agent FF-10501 in the US to treat patients with advanced haematologic...

      Exelixis’ Phase III prostate cancer trial of cabozantinib fails to meet primary endpoint

      Americas
      US-based biopharmaceutical firm Exelixis has reported disappointing top-line results from the final analysis of COMET-1, the Phase III trial of cabozantinib in men with...

      Asterias to begin AST-OPC1 Phase I/IIa trial to treat spinal cord injury

      Americas
      The US Food and Drug Administration (FDA) has granted clearance to Asterias Biotherapeutics for the initiation of a Phase I/IIa clinical trial of its...

      Mesoblast and NIH partner on 120-patient trial to treat end-stage heart failure

      Americas
      Australia-based regenerative medicine company Mesoblast has signed an agreement with the US National Institutes of Health's (NIH) National Heart, Lung and Blood Institute to...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      © 2025 Copyright © Valuemediaservices 2025 All rights reserved.